Correction to Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

• Yuzhong Cui ^[1] ; Wei Huang ^[2] ; Feng Du ^[3] ; Xiaoyang Yin ^[2] ; Lei Feng ^[2] ; Baosheng Li ^[2]
  1. [1] Tianjin Medical University

     Tianjin Medical University

     China

     
  2. [2] Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China
  3. [3] Department of Oncology, Zibo Municipal Hospital, Zibo, 255400, China

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 25, Nº. 2 (February), 2023, págs. 560-562
• Idioma: inglés
• Texto completo no disponible (Saber más ...)